Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • NCE Meeting Abstracts
  • AAP Policy
  • Supplements
  • Multimedia
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • NCE Meeting Abstracts
  • AAP Policy
  • Supplements
  • Multimedia
  • Subscribe
  • Alerts
  • Careers
American Academy of Pediatrics
ASTHMA: β-ADRENERGIC AGONIST THERAPY

BRONCHODILATOR THERAPY AND HYPERACTIVITY IN PRESCHOOL CHILDREN

John M. Kelso
Pediatrics August 2003, 112 (Supplement 2) 482;
John M. Kelso
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • Comments
Loading
Download PDF

Hadjikoumi I, Loader P, Bracken M, Milner AD. Arch Dis Child. 2002;86:202–203

Purpose of the Study.

Parents often report that nebulized albuterol makes their children “hyper.”

Study Population.

Nineteen children with asthma 25 to 64 months of age whose parents thought that albuterol made their children overactive.

Methods.

This was a double-blind, crossover study with children randomized to receive nebulization with albuterol (5 mg) or saline, then the reverse [Note: the usual dose is 0.5 mL of the 0.5% solution = 2.5 mg]. Behavior was rated by parents using Connors’ Rating Scale at baseline and after nebulization. Professional observers rated the level of activity using Preschool Behavior Observation Scale (PS-BOS).

Results.

Parental ratings of activity revealed no significant difference between baseline and postalbuterol scores. Professional observers ratings of activity revealed no evidence of an increase in the child’s activity after administration of albuterol.

Conclusions.

Neither parental report nor observer ratings suggested any significant increase in the child’s level of activity after albuterol.

Reviewer’s Comments.

Although often reported, when studied in a blinded fashion, an albuterol nebulization, even 5 mg, does not cause preschoolers to be “hyper.” Perhaps it is the setting (asthma attack) in which a nebulization is normally given that changes children’s behavior or their parents perception thereof.

View Abstract
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 112, Issue Supplement 2
1 Aug 2003
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
BRONCHODILATOR THERAPY AND HYPERACTIVITY IN PRESCHOOL CHILDREN
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
Request Permissions
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
BRONCHODILATOR THERAPY AND HYPERACTIVITY IN PRESCHOOL CHILDREN
John M. Kelso
Pediatrics Aug 2003, 112 (Supplement 2) 482;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
BRONCHODILATOR THERAPY AND HYPERACTIVITY IN PRESCHOOL CHILDREN
John M. Kelso
Pediatrics Aug 2003, 112 (Supplement 2) 482;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Purpose of the Study.
    • Study Population.
    • Methods.
    • Results.
    • Conclusions.
    • Reviewer’s Comments.
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

ASTHMA: β-ADRENERGIC AGONIST THERAPY

  • LOW-DOSE LEVALBUTEROL IN CHILDREN WITH ASTHMA: SAFETY AND EFFICACY IN COMPARISON WITH PLACEBO AND RACEMIC ALBUTEROL
  • β2-AGONIST TOLERANCE AND EXERCISE-INDUCED BRONCHOSPASM
  • 1-YEAR EFFICACY AND SAFETY OF INHALED FORMOTEROL DRY POWDER IN CHILDREN WITH PERSISTENT ASTHMA
Show more ASTHMA: β-ADRENERGIC AGONIST THERAPY

ABSTRACTS

  • LOW-DOSE LEVALBUTEROL IN CHILDREN WITH ASTHMA: SAFETY AND EFFICACY IN COMPARISON WITH PLACEBO AND RACEMIC ALBUTEROL
  • β2-AGONIST TOLERANCE AND EXERCISE-INDUCED BRONCHOSPASM
  • 1-YEAR EFFICACY AND SAFETY OF INHALED FORMOTEROL DRY POWDER IN CHILDREN WITH PERSISTENT ASTHMA
Show more ABSTRACTS

Similar Articles

Subjects

  • Allergy/Immunology
    • Allergy/Immunology
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2019 American Academy of Pediatrics